Podcast URL Show Notes There are new NASH Guidelines and we're gonna talk about them. Who better to chat with than lead author Dr. Mary Rinella? Probably nobody! But first, the precarities of being an...
Adam Winters
Alex Vogel
GLP-1 agonists are approved for the treatment of diabetes and for obesity. Why are patients with non-alcoholic fatty liver disease (NAFLD) suddenly being prescribed GLP-1 agonists and what are the...
Melissa Kaltenbach
Does weight loss really help with managing NASH?
Richie Manikat
https://aasldpubs.onlinelibrary.wiley.com/doi/full/10.1002/hep.32244 More benefits of good glycemic control in patients with NAFLD!
Chiara Maruggi
Are there any treatment options for medical management of NASH? Find out in this summary of the PIVENS Trial!
Does the stage of fibrosis predict outcomes in NAFLD?
If you are curious if bariatric surgery is safe and effective in patients with NASH, this is the study for you. https://jamanetwork.com/journals/jama/article-abstract/2786270
To read the full article: https://tinyurl.com/cnkzsjmn
Erin Cleveland
NAFLD is a widespread etiology for liver disease in the pediatric population; however the gold standard for diagnosis, a liver biopsy, is an invasive procedure. This study sought to assess the...
Kayla Hartjes
Effective treatments for NASH have been elusive. Is Semaglutide the answer people have been waiting for?
Jennifer Wang
Enter your email here and receive monthly newsletters with new LFN material.
Registration failed. Please try again later.
